MENU
+Compare
RDGT
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$1.38
Change
-$0.03 (-2.13%)
Capitalization
8.1M

RDGT stock forecast, quote, news & analysis

Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products... Show more

RDGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for RDGT with price predictions
Sep 05, 2025

RDGT in -5.68% downward trend, falling for three consecutive days on September 03, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RDGT declined for three days, in of 326 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

RDGT broke above its upper Bollinger Band on September 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where RDGT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 04, 2025. You may want to consider a long position or call options on RDGT as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RDGT just turned positive on September 04, 2025. Looking at past instances where RDGT's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

RDGT moved above its 50-day moving average on September 04, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDGT advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RDGT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.273) is normal, around the industry mean (9.099). P/E Ratio (0.000) is within average values for comparable stocks, (49.842). RDGT's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.923). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. P/S Ratio (0.064) is also within normal values, averaging (12.758).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RDGT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 3.62B. The market cap for tickers in the group ranges from 3.29K to 26.2B. JDHIF holds the highest valuation in this group at 26.2B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 3%. ALBHF experienced the highest price growth at 22%, while HKPD experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was 677%. For the same stocks of the Industry, the average monthly volume growth was 889% and the average quarterly volume growth was 729%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 70
Price Growth Rating: 59
SMR Rating: 78
Profit Risk Rating: 96
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
RDGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

an operator of retail pharmacy chain

Industry DrugstoreChains

Profile
Fundamentals
Details
Industry
Drugstore Chains
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A